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During the last years many articles have reported epithelial-to-mesenchymal transitions
(EMT) induced by a myriad of gene products either when added to the cell medium
or when transfected. Molecularly the EMT is characterized by the up-regulation of
transcriptional factors (EMT-TFs) repressing the epithelial gene E-cadherin, a protein
essential for the maintenance of the epithelial phenotype. These EMT-TFs are subjected to
a complex regulation involving binary self-stimulatory loops, allowing the possibility of the
amplification of input signals. The capability of EMT-TFs to promote an EMT is controlled
by E-cadherin that limits the transcription of mesenchymal genes. We discuss here the
differences between normal and tumor epithelial cells; in the latter a partial inactivation of
E-cadherin function enables extracellular signals to be amplified and induce an EMT. This
tumor cell phenotypic instability is exacerbated in cell culture conditions. Therefore, it is
likely that many of the gene products reported to control this transition act only in very
specific cell tumor cell lines; thus, in cells with an unstable phenotype due to pre-existing
alterations in E-cadherin safeguard mechanism.
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TRANSCRIPTIONAL FACTORS CONTROL EMT
Epithelial to Mesenchymal transition (EMT) was initially
described by Elizabeth Hay decades ago (Hay, 1968); in the 80’s
and 90’s several groups reported the acquisition of a fibroblastic,
scattered or undifferentiated phenotype after prolonged treat-
ments of epithelial cells with cytokines such as TGF-β. EMT is
characterized by an extensive down-modulation of the key epithe-
lial gene E-cadherin and the induction of mesenchymal markers,
such as Fibronectin or Vimentin (Nieto, 2011). However, it was at
the beginning of 2000 when EMT started to be widely studied fol-
lowing the description of transcriptional repressors that directly
act on E-cadherin gene, inhibiting its expression and inducing
the acquisition of a mesenchymal phenotype by epithelial cells
(Batlle et al., 2000; Cano et al., 2000; Grooteclaes and Frisch,
2000; Comijn et al., 2001; Hajra et al., 2002; Yang et al., 2004).
Among these transcriptional factors, the Snail family, particu-
larly Snail1, has received more attention although the Zeb and
Twist families have also been extensively studied. All these fac-
tors will be referred below as EMT-related transcription factors
(EMT-TFs).
Transfection of Snail1, Zeb1 or Twist1 induces an EMT in
most cell lines (Batlle et al., 2000; Cano et al., 2000; Grooteclaes
and Frisch, 2000; Comijn et al., 2001; Hajra et al., 2002; Yang
et al., 2004). When compared, Zeb1 is more potent as E-cadherin
repressor whereas Twist induces bettermesenchymal genes; Snail1
seems to gather both properties (Garcia de Herreros and Baulida,
2012). Snail1 ectopic expression induces Zeb1 expression; how-
ever, Zeb1 does not alter Snail1 levels which suggests that Zeb1
(Nieto, 2011) is downstream Snail1 in the signaling pathway
controlling EMT (Garcia de Herreros and Baulida, 2012). Twist
and Snail1 seem to reside in parallel branches since only very
occasionally they activate each other (at least transcriptionally),
although both cooperatively induce Zeb1 (Dave et al., 2011). The
complementary role of both factors is also demonstrated by devel-
opmental studies indicating that during gastrulation Twist hypo-
morphic mutants are rescued by Snail1 overexpression (Wong
et al., 2014).
Kinetically Snail1 is the first factor to be up-regulated during
cytokine-driven g EMT (Peinado et al., 2007). For instance, in the
broadly used system of mammary murine NMuMG cells exposed
to TGF-β, Snail1 up-regulation is detected as early as 30min after
TGF-β addition whereas Zeb1 or other mesenchymal markers
require 4–6 h and Twist1 is not consistently increased (Dave et al.,
2011). This activation of Snail1 protein is transient whereas that
of Zeb1 is not. Due to these results Snail1 has been considered
as the transcriptional factor triggering EMT, whereas Zeb1 would
be responsible for the consolidation of the mesenchymal pheno-
type by repressing E-cadherin and other epithelial genes (Peinado
et al., 2007; Garcia de Herreros and Baulida, 2012).
The EMT-TFs present common features. For instance all
Snail1/2, Zeb1/2 and Twist are very unstable proteins with half-
lives around 30min (Diaz et al., in press). Different ubiquitin
ligases have been characterized acting specifically on one, two, or
even three of these factors (Diaz et al., in press); therefore, down-
regulation of these ubiquitin ligases is capable to trigger EMT
(Viñas-Castells et al., 2014; Zheng et al., 2014).
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SIGNALING PATHWAYS CONTROLLING EMT SHOW
POSITIVE AND NEGATIVE FEED-BACK LOOPS
EMT-TFs gene expression is dependent on the activity of several
common and ubiquitous transcriptional factors, such as NF-
κB, β-catenin/Tcf-4 and Ets-2 (Garcia de Herreros and Baulida,
2012; De Craene and Berx, 2013). Since activation of these fac-
tors can be achieved by several extracellular cues, it should be
expected that EMT is induced by these signals although this is
not the case; for instance Snail1 transcription can be up-regulated
by factors, such as TNFα or Wnt3a, that normally do not pro-
mote an EMT. It is possible that the extent, or more likely the
continuity, of the stimulation might be relevant and a persis-
tent up-regulation, for instance in β-catenin/Tcf-4 transcriptional
activity, might promote an EMT. Alternatively, this transition
might also require the convergence of signals acting on two of
these transcriptional complexes, or the activation of not only
the transcription but also the stabilization of key genes such
as Snail1. This can also apply to some other levels of control
since the mRNA stability of many EMT-TFs is also controlled by
miRNAs.
Moreover, the study of the transduction pathways control-
ling the expression of EMT-TFs has revealed that these path-
ways are not linear but display numerous points of self-control
either positive or negative. It has been demonstrated the exis-
tence of binary circuits composed by two genes that negatively
regulate each other; for instance in the systems miR-34a/Snail1
and miR-200/Zeb1, the EMT-TF inhibits the miRNA acting
on the same TF (Bracken et al., 2008; Burk et al., 2008; Kim
et al., 2011; Siemens et al., 2011) (Figure 1). This creates a
positive feed-back loop since increases in Snail1, for instance,
inhibits its repressor miR-34a and further stimulates Snail1
mRNA stability. Other examples are provided by the action of
the transcriptional complexes mentioned above; stimulation of
the canonical Wnt pathway induces the repression of E-cadherin
through the stimulation of β–catenin/TCF-4 dependent-EMT-
TFs (such as Zeb1), releasing more β-catenin and enhancing
the activity of this transcriptional complex, therefore amplify-
ing the initial signal (Garcia de Herreros and Baulida, 2012).
On the contrary, Snail1 also represses its own synthesis, either
by direct binding to SNAIL promoter or by blocking the activ-
ity of Egr-1, a Snail1-gene transcriptional activator (Grotegut
et al., 2006; Peiro et al., 2006). A theoretical analysis of these
circuits has suggested that the EMT process is bi-stable, and
an intermediate epithelial-mesenchymal hybrid phenotype also
presents stability (Lu et al., 2014). Another study using human
breast epithelial MCF10A cells treated with TGF-β also describe
the existence of this intermediate phenotype that, contrar-
ily to the full mesenchymal state, is reversible upon elimina-
tion of the cytokine (Zhang et al., 2014). The existence of
this partial EMT is consistent with observations in carcino-
mas where co-expression of epithelial and mesenchymal markers
has been detected in the same cells. However, in most tumors
this intermediate phenotype looks much more epithelial than
mesenchymal and maintains most of the epithelial structures,
which suggests that the balance is biased toward the epithelium
linage.
FIGURE 1 | EMT-TFs are controlled by self-inhibition and self-activation.
The figure shows examples of mechanisms of self-inhibition (left) or
activation (right) controlling the expression of Snail1, Twist1, and Zeb1. The
number indicates the type of control. Besides the references indicated in the
text, the mechanisms shown in this figure are documented in Howe et al.
(2003), Barberà et al. (2004), Bachelder et al. (2005), Yook et al. (2006), Julien
et al. (2007), Stemmer et al. (2008), Kudo-Saito et al. (2009), Wu et al. (2009),
Sánchez-Tillo et al. (2011).
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E-CADHERIN PROTEIN PROTECTS FROM EMT
The most relevant gene product for the maintenance of
the epithelial phenotype is E-cadherin. As it is well known,
E-cadherin is required for the formation of adherens junction;
however its role is not limited to this since it binds and restrains
the transcriptional activity of β-catenin (Valenta et al., 2012) that,
as commented above, is required for the expression of EMT-TFs.
A similar negative action of E-cadherin has also been reported on
NF-κb activity (Kuphal et al., 2004; Solanas et al., 2008). Although
in this case the biochemical basis is not well characterized it relies
in the interaction of NF-kB with the adherens junction complex
(Deng et al., 2002; Solanas et al., 2008). This E-cadherin role
limiting the transcriptional role of β–catenin, NF-κB and per-
haps Ets-2 is essential for the control of EMT and the activity
of EMT-TFs. Accordingly, E-cadherin ectopic expression prevents
the induction of mesenchymal genes in several models of EMT
(Ohkubo and Ozawa, 2003; Solanas et al., 2008). Although it is
not sufficient by itself, since only very occasionally E-cadherin
down-regulation induces mesenchymal markers, the decrease in
the levels or function of this protein is absolutely necessary for
a full EMT. As we present in our model, shown in Figure 2,
cells presenting static adherens junctions are not receptive for
signals promoting an EMT. Although Snail1 is induced and
eventually down-regulate E-cadherin gene transcription, since
E-cadherin protein when present in the adherens junction is pro-
tected from degradation (Gumbiner, 2005), this Snail1-induced
mRNA decrease will not be translated in a down-regulation
in E-cadherin protein. In addition, the stable junctional com-
plexes retain β-catenin and NF-kB and restrain their traffic to the
nucleus and their transcriptional activity on mesenchymal genes
(Kuphal et al., 2004; Solanas et al., 2008). Therefore, E-cadherin
acts as safeguard of the epithelial phenotype preventing transient
signals to be amplified and promote undesired EMT. Thus, this
transition will require additional signals that decrease adherens
junction stability and make cells receptive to EMT-TFs action.
TUMOR CELLS ARE PRONE TO EMT
Accordingly, it is expected that epithelial cancer cells will be
much more susceptible to EMT than non-transformed epithe-
lium (Figure 2). Total or partial loss of adherens junctions is
a common alteration in neoplastic cells normally due to post-
translational modifications of E-cadherin-associated proteins; for
instance β-catenin tyrosine phosphorylation decreases its inter-
action with E-cadherin and causes adherens junction instability
FIGURE 2 | Tumor cells are more receptive to signals inducing EMT.
According to our model, an epithelial cell with functional E-cadherin and
stable adherens junctions is not sensitive to extracellular signals inducing
Snail1 and EMT such as TGF-β (left). Although these cytokines activate Snail1
expression, due to the high stability of E-cadherin protein the down-regulation
in E-cadherin mRNA is not translated in changes in the protein. Moreover,
stable junctional complexes retain β-catenin and NF-κB restrained their traffic
to the nucleus and transcriptional activity. In these conditions Snail1
expression is self-inhibited and the EMT process is not initiated. Tumor
epithelial cells contain less static adherens junctions due to post-translational
modifications of E-cadherin or associated proteins, such as β-catenin;
consequently the stability of E-cadherin protein is lower. In these conditions
Snail1 increases do cause a significant down-modulation in E-cadherin protein
and facilitates the traffic of NF-κB ad β-catenin to the nucleus and the
activation of their transcriptional activity. These two factors further stimulate
Snail1 expression, either by directly stimulating Snail gene transcription
(NF-κB) or increasing protein stability (NF-κB, β-catenin), therefore amplifying
the initial signal. Moreover, they also up-regulate the transcription of other
mesenchymal markers such as Zeb1 or fibronectin (FN1), triggering a
self-stimulatory circuit described in Figure 1 and supporting the EMT.
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(Lilien and Balsamo, 2005). This modification is induced by ras
or growth factor receptors, elements of a pathway commonly
activated in many types of cancers. Moreover, other signaling
pathways can weaken E-cadherin with p-120-catenin and favors
E-cadherin degradation (Kourtidis et al., 2013). Therefore, trans-
formed epithelial cells can be considered as “primed” epithelial
cells capable to respond to cytokines such as TGF-β initiating an
EMT.
Cell culture studies add a further level of instability to the
phenotype. Tumor cell lines are normally cultured in the pres-
ence of high serum concentration, a condition that stimulates
growth factor receptors. In these conditions many cells do not
form compact colonies, at least at low confluence what makes
adherens junctional complexes more unstable. Actually, Snail1-
induced EMT is much more rapid and complete when cells are
cultured at low confluence since the effect of this TF is muchmore
rapidly translated in changes in E-cadherin protein levels. Even
without additional signals, the phenotype of some tumor cells
within the intermediate state is very much dependent on the con-
fluence showing an epithelial morphology at high density and a
more mesenchymal one at low confluence (Conacci-Sorrell et al.,
2003).
Therefore, it is likely that many of the factors reportedly
involved in the control of EMT have only an effect restricted to
specific tumor cells presenting a partially inactivated E-cadherin
and likely accumulating other alterations. Due to their intrinsic
genomic instability, tumor cells might have alterations in genes
controlling the EMT-TFs; for instance, a mutation in one of the
ubiquitin ligases controlling Snail1 might enhance Snail1 up-
regulation by factors activating Snail1 transcription. Once Snail1
have reached a threshold, the EMT process would be amplified
by the self-stimulatory circuits and the loss of safeguard mech-
anisms. These alterations can affect to the many gene products
acting on the different levels of control of EMT; thus on EMT-
TFs transcription, mRNA stability or protein half-life. Thus,
tumor cells would not just present genetic but also phenotypic
instability, an alteration exacerbated in culture conditions.
Another interesting point is the discrepancy between the
results obtained in vitro, in cell lines, showing that EMT is
induced by many different conditions and factors, and in vivo,
in human tumors, where few cells are detected that have under-
gone or are in the process of undergoing an EMT (Thompson
et al., 2005). It is possible that in human tumors the cellular con-
ditions (cell to cell contacts, composition of tumor stroma) do
not enable a full EMT and most cells only respond partially to
the same conditions than in vitro promote a very extensive tran-
sition. In any case, this partial EMT obtained in vivomight result
in the acquisition of some mesenchymal markers and increased
invasion maintaining most of epithelial features. It is expected
that this EMT is more easy to be observed in the tumor border,
where epithelial cell-to-cell interactions are more relaxed due to
fewer physical constrains and also to the existence of extracellular
cues provided by stromal cells.
Therefore, although nothing can be dismissed in cancer, it is
likely that many of the described regulators of EMT present a very
limited relevance in vivo. The physiological implication of the
many proteins reported to be involved in EMT requires further
investigation, not limited to a specific cell line in culture but to
animal models or at least to a panel of cell lines. This would allow
unveiling the most relevant gene products involved in the control
of this essential cellular conversion.
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